Thursday, May 19, 2022
wellness India Expo
Home Tags Japan

Tag: Japan

CEPI partners with Japan’s NEC Group to develop AI-designed broadly protective...

If this innovative approach is proven to be successful, it may also be applicable for developing vaccines against other pathogens in the CEPI portfolio

APAC News: Japan inches closer to having its own indigenous Covid-19...

Delay in launch of indigenous COVID-19 vaccines by Japanese pharma will impact domestic market potential

Amazing nanoparticles from Maize: A potent & economical anti-cancer therapeutic

Japanese researchers develop a nanoparticle-based drug delivery system from corn/maize to target cancer cells

Novel vaccine may yield affordable solution to lipid disorders

Scientists develop a new candidate vaccine that improves obesity-related disorders and may be economical

Novel light-based method shows the changing face of bioactive molecules

Using a photocatalyst, scientists have identified the factors behind racemization process of chiral sulfoxides......................

“IQVIA offers a custom-built delivery model for biotech industry”

This edition of Chat with BioVoice features Suneela Thatte, Vice President & Head, R & D Solutions, IQVIA India who believes that the demand for faster and better drug development brought on by the pandemic is only going to accelerate the adoption of digital technologies........................

Sun Pharma announces 5-year sustained efficacy & safety results for its...

ILUMYA is the first IL-23 inhibitor to complete five years of study based on a pooled analysis of two Phase 3 efficacy and safety extension trials in moderate-to-severe plaque psoriasis.......................

Sun Pharma’s plaque psoriasis drug ILUMYA gets approval in Japan

The drug offers a new treatment option with only one injection every 12 weeks for Japanese patients who struggle everyday with the chronic nature of plaque psoriasis..........................

India invites Japanese companies to invest in pharma & medical devices...

In a webinar, the top Indian officials presented the sectoral view and the investment opportunities in the pharmaceutical and medical device industry in India to Japanese industry representatives.......................

C-CAMP’s global funding program: 300K USD per startup under CBIH

C-CAMP – BNV Innovation Hub (CBIH) is calling for applications from Indian bio startups for funding support of up to 300,000 USD or approximately 2.1 Cr INR per startup....................